A client with PTSD reports nightmares, flashbacks, and hypervigilance. Which treatment combination is most appropriate?

Choice A reason: While exposure therapy is a valid component of trauma treatment, benzodiazepines are generally contraindicated for long-term PTSD management. They can interfere with the therapeutic process of habituation and extinction of fear memories and carry a high risk of dependency and substance use disorders in this vulnerable population. Choice B reason: Psychoanalysis is a long-term approach that may not address the acute, distressing symptoms of PTSD effectively. Antipsychotics are not first-line treatments and are typically reserved for patients who exhibit comorbid psychotic features or severe, treatment-resistant aggression that has not responded to standard trauma-focused therapeutic modalities and antidepressants. Choice C reason: Group therapy provides social support but is usually an adjunct rather than the primary evidence-based intervention for core PTSD symptoms. Beta-blockers may help manage peripheral autonomic symptoms like tachycardia, but they do not address the underlying cognitive distortions or the affective components of flashbacks and nightmares as effectively as SSRIs. Choice D reason: TF-CBT is the most robust evidence-based psychotherapeutic intervention for addressing the cognitive and behavioral aspects of PTSD. Selective serotonin reuptake inhibitors (SSRIs) are the first-line pharmacological treatment, as they help regulate mood, reduce anxiety, and diminish the frequency and intensity of intrusive symptoms, nightmares, and hyperarousal.